Literature DB >> 1658049

Acceleration of the thrombin inactivation of single chain urokinase-type plasminogen activator (pro-urokinase) by thrombomodulin.

G A de Munk1, E Groeneveld, D C Rijken.   

Abstract

The in vitro effects of thrombomodulin on the inactivation of single chain urokinase-type plasminogen activator (scu-PA) by thrombin were investigated by incubating scu-PA with varying concentrations of human thrombin, in both the absence and presence of soluble rabbit thrombomodulin. 50% inactivation of scu-PA occurred in 45 min at 160 ng/ml thrombin in the absence of thrombomodulin and at 4.6 ng/ml thrombin in the presence of thrombomodulin. No difference was found in either the absence or the presence of thrombomodulin between the inactivation rates of high molecular weight scu-PA, and a low molecular weight scu-PA which lacked the growth factor and kringle domains. Enzyme kinetic experiments with varying concentrations of scu-PA showed that thrombomodulin decreased the Km of thrombin for scu-PA from 7.8 to 0.43 microM and increased the kcat from 0.30 to 1.2 s-1, corresponding to a 70-fold increase in the second-order rate constant kcat/Km. SDS-polyacrylamide gel electrophoresis showed that scu-PA was cleaved into two chains upon inactivation by thrombin, and confirmed the acceleration effect of thrombomodulin on inactivation of scu-PA. Thrombomodulin thus not only has anticoagulant properties but is also antifibrinolytic. The acceleration may imply a new mechanism for the regulation of local plasminogen activator activity on the cell surface.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1658049      PMCID: PMC295701          DOI: 10.1172/JCI115483

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  31 in total

1.  Comparative thrombolytic properties of single-chain forms of urokinase-type plasminogen activator.

Authors:  D C Stump; J M Stassen; E Demarsin; D Collen
Journal:  Blood       Date:  1987-02       Impact factor: 22.113

2.  Characterization and fibrin-binding properties of different molecular forms of pro-urokinase from a monkey kidney cell culture.

Authors:  G Wijngaards; D C Rijken; A L van Wezel; E Groeneveld; C A van der Velden
Journal:  Thromb Res       Date:  1986-06-15       Impact factor: 3.944

Review 3.  Single-chain urokinase-type plasminogen activator: mechanism of action and thrombolytic properties.

Authors:  H R Lijnen; D C Stump; D C Collen
Journal:  Semin Thromb Hemost       Date:  1987-04       Impact factor: 4.180

4.  Specific fibrinolytic properties of different molecular forms of pro-urokinase from a monkey kidney cell culture.

Authors:  D C Rijken; D J Binnema; P Los
Journal:  Thromb Res       Date:  1986-06-15       Impact factor: 3.944

5.  Activation with plasmin of tow-chain urokinase-type plasminogen activator derived from single-chain urokinase-type plasminogen activator by treatment with thrombin.

Authors:  H R Lijnen; B Van Hoef; D Collen
Journal:  Eur J Biochem       Date:  1987-12-01

6.  The activation of pro-urokinase by plasma kallikrein and its inactivation by thrombin.

Authors:  A Ichinose; K Fujikawa; T Suyama
Journal:  J Biol Chem       Date:  1986-03-15       Impact factor: 5.157

Review 7.  Plasminogen activators, tissue degradation, and cancer.

Authors:  K Danø; P A Andreasen; J Grøndahl-Hansen; P Kristensen; L S Nielsen; L Skriver
Journal:  Adv Cancer Res       Date:  1985       Impact factor: 6.242

8.  Inactivation of single-chain urokinase (pro-urokinase) by thrombin and thrombin-like enzymes: relevance of the findings to the interpretation of fibrin-binding experiments.

Authors:  V Gurewich; R Pannell
Journal:  Blood       Date:  1987-03       Impact factor: 22.113

Review 9.  Activation of fibrin-bound plasminogen by pro-urokinase and its complementariness with that by tissue plasminogen activator.

Authors:  V Gurewich
Journal:  Enzyme       Date:  1988

10.  Comparative kinetic analysis of the activation of human plasminogen by natural and recombinant single-chain urokinase-type plasminogen activator.

Authors:  H R Lijnen; B Van Hoef; D Collen
Journal:  Biochim Biophys Acta       Date:  1986-12-10
View more
  4 in total

Review 1.  Thrombomodulin and its role in inflammation.

Authors:  Edward M Conway
Journal:  Semin Immunopathol       Date:  2011-07-31       Impact factor: 9.623

Review 2.  Fibrinolysis and the control of blood coagulation.

Authors:  John C Chapin; Katherine A Hajjar
Journal:  Blood Rev       Date:  2014-09-16       Impact factor: 8.250

3.  Role of the glycosaminoglycan component of thrombomodulin in its acceleration of the inactivation of single-chain urokinase-type plasminogen activator by thrombin.

Authors:  G A de Munk; J F Parkinson; E Groeneveld; N U Bang; D C Rijken
Journal:  Biochem J       Date:  1993-03-15       Impact factor: 3.857

4.  Thrombomodulin expression in colorectal carcinoma is protective and correlates with survival.

Authors:  A M Hanly; M Redmond; D C Winter; S Brophy; J M Deasy; D J Bouchier-Hayes; E W Kay
Journal:  Br J Cancer       Date:  2006-05-08       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.